BiotechTube

BAY1817080 + Placebo + Itraconazole

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Clinical Trials, Phase I as Topic

Conditions

Clinical Trials, Phase I as Topic

Trial Timeline

Jul 22, 2016 → Aug 23, 2017

NCT ID
NCT02817100

About BAY1817080 + Placebo + Itraconazole

BAY1817080 + Placebo + Itraconazole is a phase 1 stage product being developed by Bayer for Clinical Trials, Phase I as Topic. The current trial status is completed. This product is registered under clinical trial identifier NCT02817100. Target conditions include Clinical Trials, Phase I as Topic.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02817100Phase 1Completed

Competing Products

20 competing products in Clinical Trials, Phase I as Topic

See all competitors
ProductCompanyStageHype Score
Lecanemab + PlaceboEisaiPhase 3
77
Cetuximab + CisplatinEli LillyPhase 2
52
Durvalumab + TremelimumabAstraZenecaPhase 1/2
41
PosaconazoleMerckApproved
85
Rebif®MerckPhase 3
77
Blinatumomab + olverembatinibAmgenPhase 2
51
Binimetinib + NivolumabBristol Myers SquibbPhase 2
51
Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM)BayerPhase 1
30
Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspra®) + PlaceboBayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)BayerPhase 1
30
Fulacimstat (BAY1142524)BayerPhase 1
30
Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon PlaceboBayerPhase 1
30
Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetilBayerPhase 1
30
BAY1902607 + PlaceboBayerPhase 1
30
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)BayerPhase 1
30
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + PlaceboBayerPhase 1
30
Neladenoson bialanate (BAY 1067197)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30
Vilaprisan (BAY1002670)BayerPhase 1
30

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82